Blair William & CO Incyte Corp Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Incyte Corp stock. As of the latest transaction made, Blair William & CO holds 20,934 shares of INCY stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,934

Previous 21,629 3.21%

Holding current value

$1.47 Million

Previous $1.31 Million 5.49%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$57.33 - $68.61 $39,844 - $47,683	-695 Reduced 3.21%	20,934 $1.38 Million
Q2 2024 Aug 12, 2024	SELL	$51.18 - $63.75 $739,295 - $920,868	-14,445 Reduced 40.04%	21,629 $1.31 Million
Q1 2024 May 09, 2024	SELL	$56.55 - $66.59 $4,071 - $4,794	-72 Reduced 0.2%	36,074 $2.06 Million
Q4 2023 Feb 12, 2024	SELL	$52.16 - $64.19 $1.06 Million - $1.3 Million	-20,264 Reduced 35.92%	36,146 $2.27 Million
Q3 2023 Nov 09, 2023	SELL	$57.77 - $65.93 $1.48 Million - $1.69 Million	-25,632 Reduced 31.24%	56,410 $3.26 Million
Q2 2023 Aug 11, 2023	BUY	$60.95 - $75.51 $1.61 Million - $2 Million	26,482 Added 47.66%	82,042 $5.11 Million
Q1 2023 May 12, 2023	SELL	$70.23 - $86.01 $37,643 - $46,101	-536 Reduced 0.96%	55,560 $4.02 Million
Q4 2022 Feb 10, 2023	BUY	$67.18 - $84.11 $2.63 Million - $3.29 Million	39,162 Added 231.26%	56,096 $4.51 Million
Q3 2022 Nov 09, 2022	SELL	$66.18 - $82.86 $115,285 - $144,342	-1,742 Reduced 9.33%	16,934 $1.13 Million
Q2 2022 Aug 10, 2022	BUY	$66.18 - $83.18 $1,191 - $1,497	18 Added 0.1%	18,676 $1.42 Million
Q1 2022 May 13, 2022	BUY	$66.02 - $79.71 $232,126 - $280,260	3,516 Added 23.22%	18,658 $1.48 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $959,094 - $1.12 Million	15,142 New	15,142 $1.11 Million
Q2 2019 Aug 13, 2019	SELL	$73.52 - $88.7 $222,324 - $268,228	-3,024 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$63.56 - $88.17 $192,205 - $266,626	3,024 New	3,024 $260,000
Q2 2018 Aug 13, 2018	SELL	$60.85 - $83.98 $296,035 - $408,562	-4,865 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $404,086 - $491,267	4,865 New	4,865 $405,000
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $372,555 - $464,301	-3,982 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$109.15 - $138.27 $434,635 - $550,591	3,982	3,982 $465,000

Others Institutions Holding INCY

# of Institutions

642

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account